定制上颌口腔矫治器与下颌前移矫治器治疗中度阻塞性睡眠呼吸暂停患者疗效比较:随机对照试验方案
本研究为前瞻性随机对照试验方案,拟纳入40例多导睡眠图记录呼吸暂停低通气指数>15-30的中度阻塞性睡眠呼吸暂停患者,随机分为下颌前移矫治器组(n=20)与定制上颌口腔矫治器组(n=20)。在基线、佩戴矫治器后1个月和3个月评估呼吸暂停低通气指数、血氧饱和度、快速眼动百分比、脑电图、心电图、口鼻气流及Epworth嗜睡量表,比较两组差异。作者预期定制上颌口腔矫治器在管理中度阻塞性睡眠呼吸暂停方面较下颌前移矫治器更有效。
要点
- 方案拟纳入40例呼吸暂停低通气指数>15-30的中度阻塞性睡眠呼吸暂停患者。
- 随机分为下颌前移矫治器组(n=20)与定制上颌口腔矫治器组(n=20)。
- 在基线、1个月和3个月评估呼吸暂停低通气指数、血氧饱和度、快速眼动百分比、脑电图、心电图、口鼻气流及Epworth嗜睡量表。
核心结论
- 作者预期定制上颌口腔矫治器在管理中度阻塞性睡眠呼吸暂停方面较下颌前移矫治器更有效。
- 若本研究假设得到证实,该定制上颌矫治器将被引用为管理中度阻塞性睡眠呼吸暂停的金标准。
研究设计与样本
- 前瞻性干预性随机对照试验方案,拟纳入40例多导睡眠图记录呼吸暂停低通气指数>15-30的中度阻塞性睡眠呼吸暂停患者。
- 参与者随机分为下颌前移矫治器组(n=20)与定制上颌口腔矫治器组(n=20)。
- 在基线及佩戴矫治器后1个月和3个月评估呼吸暂停低通气指数、血氧饱和度、快速眼动百分比、脑电图、心电图、经压力换能器测口鼻气流及Epworth嗜睡量表。
- 使用SPSS 20.1版进行描述性与分析性统计,两组1个月和3个月比较的统计显著性以p<0.05评估。
- 试验注册号CTRI/2020/07/026936,注册日期2020年7月31日。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obstructive sleep apnea (OSA) is due to the obstruction of the upper airway during sleep. This condition is often associated with multiple symptoms and co-morbidities. There are many treatment options mentioned in the literature to manage OSA, among which interventional option of continuous positive airflow (CPAP) and non-interventional option, i.e., mandibular advancement device (MAD), which is an oral appliance (OA), are the most preferred ones. This study aims to evaluate the efficacy of customized maxillary oral appliances with mandibular advancement devices in moderate OSA patients. METHODS: A prospective interventional study with a randomized controlled trial will be carried out involving 40 participants (sample size), with an apnea-hypopnea index (AHI) > 15-30, recorded on polysomnography (PSG). Study participants will be randomly divided into the following treatment groups: control group or group subjected to mandibular advancement device (MAD, n=20) and second group subjected to customized maxillary oral appliance (CMOA, n=20). Baseline assessment of apnea/hypopnea index (AHI), oxygen saturation in blood, percentage of rapid eye movement, electroencephalogram, electrocardiogram, oro-nasal airflow via a pressure transducer, and Epworth Sleepiness Scale will be done. Then both study group participants will receive their respective appliances. And after one month and three months of delivery of the appliance, all the parameters, i.e., AHI, oxygen saturation in blood, percentage of rapid eye movement, electroencephalogram, electrocardiogram, oro-nasal airflow via a pressure transducer, and Epworth Sleepiness Scale will be re-evaluated and compared with the baseline measurements. Descriptive and analytical statistics will be done. SPSS (Statistical Package for Social Sciences) Version 20.1 will be used as statistical software. The statistical significance between the two groups after one month and three months will be evaluated at p< 0.05. DISCUSSION: We expect, customized maxillary oral appliance to be more efficient in managing moderate OSA, in comparison with MAD. If the hypothesis of the present study is confirmed, then this customized maxillary appliance will be quoted as a "gold standard" for managing moderate OSA. TRIAL REGISTRATION: CTRI/2020/07/026936 Registered 31 July 2020.
引用
- Belkhode V, Godbole S, Nimonkar S, et al. Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients-protocol for a randomized controlled trial. Trials. 2022. PMID: 35172870. doi:10.1186/s13063-022-06070-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。